Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
RFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants
10:03am, Thursday, 26'th Jun 2025
Health and Human Services Secretary Robert F. Kennedy Jr.'s revamped government panel of vaccine advisors recommended the use of Merck's shot designed to protect infants from respiratory syncytial vir
ACIP recommends Merck's RSV shot for infants under 8 months old
09:34am, Thursday, 26'th Jun 2025
CNBC's Angelica Peebles joins 'Squawk on the Street' with the latest news from the CDC.
US CDC panel votes in favor of Merck's RSV antibody drug
09:00am, Thursday, 26'th Jun 2025
An advisory panel of the U.S. Centers for Disease Control and Prevention on Thursday recommended the use of Merck's respiratory syncytial virus therapy, Enflonsia, for infants 8 months or younger, who
2 Stocks Too Cheap to Ignore at These Prices
06:45am, Thursday, 26'th Jun 2025
The S&P 500 flirted with bear-market territory earlier this year. Although it has mostly recovered, plenty of companies are still dealing with issues that have led to poor performances.
Merck Moves Past 50-Day Average: How to Play MRK Stock Now
11:01am, Wednesday, 25'th Jun 2025
MRK breaks above its 50-day average but near-term headwinds and weak China sales challenge the bullish case.
MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal
01:20pm, Tuesday, 24'th Jun 2025
Merck's Winrevair meets goal in a phase III study in newly diagnosed PAH patients, showing strong efficacy.
Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention
06:45am, Tuesday, 24'th Jun 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention.
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 HYPERION study evaluating WINREVAIR™
4 BofA Securities Strong Buy Growth 10 Stocks Also Pay Reliable Dividends
07:45am, Saturday, 21'st Jun 2025
Investors love growth stocks that also pay big and reliable dividends because they provide dependable passive income streams and an excellent opportunity for solid total return.
Why the Market Dipped But Merck (MRK) Gained Today
06:46pm, Wednesday, 18'th Jun 2025
Merck (MRK) closed at $79.29 in the latest trading session, marking a +1.29% move from the prior day.
RFK Jr weighs review of vaccines citing aluminum use, Bloomberg News reports
01:05pm, Wednesday, 18'th Jun 2025
U.S. Health Secretary Robert F. Kennedy Jr. is considering asking a key government vaccine advisory panel to examine vaccines that contain aluminum ingredients, Bloomberg News reported on Wednesday, c
RFK Jr.'s new vaccine advisors will vote on flu shots containing mercury
01:01pm, Wednesday, 18'th Jun 2025
A revamped government panel of vaccine advisors appointed by Health and Human Services Secretary Robert F. Kennedy Jr. will soon vote on a shot preservative that contains mercury, which is safely used
BASKING RIDGE, N.J. & RAHWAY, N.J.--(BUSINESS WIRE)--The first patient has been dosed in the IDeate-Prostate01 phase 3 trial evaluating the efficacy and safety of investigational ifinatamab deruxtecan
2 Dividend Stocks to Buy and Never Sell
05:02am, Wednesday, 18'th Jun 2025
There are excellent reasons to invest in dividend stocks, including the fact that they typically outperform their non-dividend-paying peers in delivering strong market returns over long periods.
Slowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards?
03:41pm, Tuesday, 17'th Jun 2025
Merck's Gardasil sales decline due to weak demand trends in China, with new launches expected to offset the downside.
